financial & production
co-ordinator
ELSABÉ BURMEISTER
Tel: 021 976 8129
Fax: 086 664 4202
Cell: 082 775 6808
e-mail:
elsabe@clinicscardive.comProduction Editor
SHAUNA GERMISHUIZEN
Tel: 021 785 7178
Cell: 083 460 8535
e-mail:
shauna@clinicscardive.comCONTENT MANAGER
Michael Meadon (Design
Connection)
Tel: 021 976 8129
Fax: 0866 557 149
e-mail:
michael@clinicscardive.comGAUTENG CONTRIBUTOR
PETER WAGENAAR
Cell 082 413 9954
e-mail:
skylark65@myconnection.co.zaThe
Cardiovascular Journal of Africa
,
incorporating the
Cardiovascular
Journal of South Africa
, is published 10
times a year, the publication date being
the third week of the designated month.
Copyright:
Clinics Cardive Publishing (Pty) Ltd.
Layout:
Martingraphix
Printer:
Tandym Print/Castle Graphics
ONLINE publishing & coding
SERVICES:
Design Connection &
Active-XML.comAll submissions to CVJA are to be
made online via
www.cvja.co.zaElectronic submission by means of an
e-mail attachment may be considered
under exceptional circumstances.
Postal address: PO Box 1013,
Durbanville, RSA, 7551
Tel: 021 976 8129
Fax: 0866 644 202
Int.: +27 21 976 8129
e-mail:
info@clinicscardive.comElectronic abstracts available on Pubmed
Audited circulation
Full text articles available on: www.cvja.
co.zaor via
www.sabinet.co.za;for access
codes contact
elsabe@clinicscardive.comSubscriptions for 6 issues:
To subscribe to the journal or change
your postal address, e-mail
elsabe@clinicscardive.comSouth Africa: R490 (incl VAT)
Overseas: $135
Online subscription: R300
The views and opinions expressed in the
articles and reviews published are those
of the authors and do not necessarily
reflect those of the editors of the Journal
or its sponsors. In all clinical instances,
medical practitioners are referred to the
product insert documentation as approved
by the relevant control authorities.
CONTENTS
Vol 29, No 5, SEPTEMBER/OCTOBER 2018
305 The impact of admission cystatin C levels on in-hospital and three-year mortality rates
in acute decompensated heart failure
H Selcuk • MT Selcuk • O Maden • KG Balci • MM Balci • S Tekeli • EH Çetin • A Temizhan
• M Balci • N Karabiber
310 The clinical prognostic significance of myocardial performance index (MPI) in stable
placental-mediated disease
I Bhorat • M Pillay • T Reddy
REVIEW ARTICLES
317 Rheumatoid arthritis and risk of cardiovascular disease
PWA Meyer • R Anderson • JA Ker • MTM Ally
322 The role of novel atherosclerosis markers in peripheral artery disease: is there a
gender difference?
H Com
ş
a • D Zdrenghea • SC Man • D Pop
PASCAR REPORT
331 Development of the certificate course in the management of hypertension in Africa
(CCMH-Africa): proceedings of the first continental faculty meeting, Nairobi, Kenya,
25–26 February 2018
A Dzudie • D Ojji • A Damasceno • MU Sani • E Kramoh • JBA Kacou • B Anisiuba • E Ogola •
M Awad • G Nel • H Otieno • AI Toure • A Kane • AP Kengne • C Ngwasiri • H Ba • S Kingue •
B Mipinda • BE Mbolla • A Weldehana • F Bukachi • B Gitura • B Kitio • B Rayner • AE Shutte •
AO Mocumbi • B Mayosi • A Jose • B Sandeep • M Weber • C Delles • F Cappuccio • H Gamra •
D Prabhakaran • N Poulter • S Subhani • on behalf of the PASCAR task force on hypertension
PUBLISHED ONLINE
(Available on
www.cvja.co.zaand in PubMed)